• Users Online: 165
  • Home
  • Print this page
  • Email this page
Home Current issue Ahead of print Search About us Abstracting and Indexing Editorial board Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Intravitreal bevacizumab for treatment of central serous chorioretinopathy

Ünlü Cihan, Erdogan Gurkan, Aydogan Tugba, Sezgin Akcay Betul Ilkay, Kardes Esra, Kiray Gulunay Akcali, Bozkurt Tahir Kansu

Year : 2016| Volume: 11| Issue : 1 | Page no: 61-65

   This article has been cited by
1 Clinical efficacy of anti-VEGF medications for central serous chorioretinopathy: a meta-analysis
Shangli Ji,Yemei Wei,Jiansu Chen,Shibo Tang
International Journal of Clinical Pharmacy. 2017; 39(3): 514
[Pubmed]  [Google Scholar] [DOI]
2 Intravitreal Ziv-Aflibercept in Treatment of Naďve Chronic Central Serous Chorioretinopathy Related Choroidal Neovascular Membrane
Nishant Radke,Charudutt Kalamkar,Amrita Mukherjee,Snehal Radke
Case Reports in Ophthalmological Medicine. 2017; 2017: 1
[Pubmed]  [Google Scholar] [DOI]
3 Diagnosed a Patient with Central Serous Chorioretinopathy? Now What?: Management of Central Serous Chorioretinopathy
Brian E. Goldhagen,Raquel Goldhardt
Current Ophthalmology Reports. 2017; 5(2): 141
[Pubmed]  [Google Scholar] [DOI]
4 Bilateral Central Scotoma Due to CSCR in an Asthmatic Policeman
Lai Chan Fhun,Evelyn Tai Li Min,Mei Fong Chong,Ahmad Tajudin Liza-Sharmini
Open Journal of Ophthalmology. 2016; 06(04): 240
[Pubmed]  [Google Scholar] [DOI]
5 Intravitreal Bevacizumab and Ranibizumab in the Treatment of Acute Central Serous Chorioretihopathy: A Single Center Retrospective Study
Kemal Tekin,Mehmet Ali Sekeroglu,Ali Bulent Cankaya,Mehmet Yasin Teke,Sibel Doguizi,Pelin Yilmazbas
Seminars in Ophthalmology. 2016; : 1
[Pubmed]  [Google Scholar] [DOI]


Read this article